Product Information
NOVOLIN R 100 UNIT/ML VIAL is a brand product labeled by Novo Nordisk, priced at $4.6249 per ML under NDC 00169183311. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
100 [iU]/mL
Manufacturer
Novo NordiskNDC
00169183311
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN HUMANApproval Type
Biologic (BLA)
FDA Application
BLA019938On Market Since
6/25/1991
Pharmacological Classes
Price Statistics
The NADAC for NOVOLIN R 100 UNIT/ML VIAL has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 42.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6249 per ML |
|---|---|
| All-time high | $13.4883 (Dec 12, 2018) |
| All-time low | $4.6226 (Apr 22, 2026) |
| 52-week high | $4.6278 |
| 52-week low | $4.6226 |
| Median price | $13.2299 |
| Average price | $11.0967 |
| Largest weekly change | -65.0% (Jan 10, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NOVOLIN R 100 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for NOVOLIN R 100 UNIT/ML VIAL, manufactured by Novo Nordisk, is $4.6249 per ML (NDC 00169183311), effective Jun 24, 2026.
How has the price of NOVOLIN R 100 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for NOVOLIN R 100 UNIT/ML VIAL has declined 42.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NOVOLIN R 100 UNIT/ML VIAL?
Since Nov 28, 2013, the NADAC for NOVOLIN R 100 UNIT/ML VIAL has ranged from a low of $4.6226 (Apr 22, 2026) to a high of $13.4883 (Dec 12, 2018), with a median of $13.2299 per ML.
Are there cheaper alternatives to NOVOLIN R 100 UNIT/ML VIAL?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, NOVOLIN N 100 UNIT/ML VIAL, is $4.6222 per ML — about 0% below NOVOLIN R 100 UNIT/ML VIAL.
Who manufactures NOVOLIN R 100 UNIT/ML VIAL?
NOVOLIN R 100 UNIT/ML VIAL (NDC 00169183311) is labeled by Novo Nordisk, and CMS classifies it as a brand product.
Related Drugs
Same classification